Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Oncosec Medical (ONCS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
OncoSec Announces $15 Million At Market Investment from Alpha Holdings, Inc.

OncoSec Medical Incorporated (OncoSec) (NASDAQ: ONCS), a company developing intratumoral cancer immunotherapies, today announced that it has secured a $15 million investment from Alpha Holdings, Inc. (KOSDAQ:...

ONCS : 1.40 (+0.72%)
OncoSec Appoints Alain Algazi, MD, as Clinical Strategic Advisor

OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company developing intratumoral cancer immunotherapies, today announced an enhancement to the company's medical and clinical leadership with the...

ONCS : 1.40 (+0.72%)
New Research: Key Drivers of Growth for OncoSec Medical, AcelRx Pharmaceuticals, Cameco, Prestige Brand, Berry Global Group, and A-Mark Precious Metals -- Factors of Influence, Major Initiatives and Sustained Production

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of OncoSec Medical Incorporated...

BERY : 50.14 (-0.77%)
ACRX : 3.95 (+6.76%)
PBH : 39.07 (+2.90%)
ONCS : 1.40 (+0.72%)
CCJ : 9.92 (-0.60%)
AMRK : 12.05 (-8.88%)
Arch Therapeutics Appoints Healthcare Industry Executive Punit Dhillon to Board of Directors

Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), developer of the AC5 Surgical Hemostatic Device(TM) ("AC5(TM)"), today announced the appointment of Punit Dhillon, former President & CEO...

NMUS : 0.2950 (-2.03%)
ONCS : 1.40 (+0.72%)
EMH.VN : 4.970 (+0.40%)
ARTH : 0.4000 (unch)
OncoSec Presents Update from Triple Negative Breast Cancer Program at 3rd Global Insight Conference on Breast Cancer

OncoSec Medical Incorporated (OncoSec) (NASDAQ: ONCS), a company developing intratumoral cancer immunotherapies, today announced that Sharron Gargosky, PhD, Chief Clinical and Regulatory Officer, presented...

ONCS : 1.40 (+0.72%)
Breakfast Technical Briefing on Tetraphase Pharma and Three Other Additional Biotech Stocks

Stock Research Monitor: ONCS, SGEN, and SLS

ONCS : 1.40 (+0.72%)
SGEN : 77.76 (-1.57%)
OncoSec Provides Outlook for Second Half of 2018

OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company developing intratumoral cancer immunotherapies, provided an update of key value-creating milestones for the second half of 2018 and a review...

ONCS : 1.40 (+0.72%)
OncoSec Added to the Russell Microcap® Index

OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company developing intratumoral cancer immunotherapies, announced today that it has been added to the Russell Microcap® Index, effective Friday,...

ONCS : 1.40 (+0.72%)
Factors of Influence in 2018, Key Indicators and Opportunity within PPL, The Travelers Companies, Xilinx, United Bankshares, DaVita, and OncoSec Medical -- New Research Emphasizes Economic Growth

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of PPL Corporation (NYSE:PPL),...

UBSI : 38.05 (-0.78%)
XLNX : 78.73 (-0.30%)
TRV : 134.44 (+0.22%)
ONCS : 1.40 (+0.72%)
PPL : 29.68 (+0.44%)
DVA : 69.92 (-0.71%)
OncoSec Expands Relationship with Merck, Announces Clinical Collaboration to Evaluate Combination of ImmunoPulse® IL-12 and KEYTRUDA® (pembrolizumab) for Triple Negative Breast Cancer

OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company developing intratumoral cancer immunotherapies, has entered a clinical trial collaboration and supply agreement with Merck (known as MSD...

ONCS : 1.40 (+0.72%)
Free Research Reports on These Biotech Stocks -- MannKind, Marinus Pharma, Mirati Therapeutics, and OncoSec Medical

If you want a free Stock Review on MNKD, MRNS, MRTX, and ONCS sign up now at www.wallstequities.com/registration. WallStEquities.com has initiated research coverage on MannKind Corp. (NASDAQ: MNKD), Marinus...

ONCS : 1.40 (+0.72%)
MRTX : 59.30 (-1.58%)
MNKD : 1.74 (+3.57%)
MRNS : 8.78 (+8.93%)
OncoSec to Present at Eighth Annual BioNJ BioPartnering Conference

OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company developing intratumoral cancer immunotherapies, today announced that Daniel J. O'Connor, Chief Executive Officer of OncoSec, will present...

ONCS : 1.40 (+0.72%)
OncoSec Announces PISCES/KEYNOTE-695 Trial-in-Progress Poster Presentation at Upcoming ASCO 2018 Annual Meeting

OncoSec Medical Incorporated (OncoSec) (NASDAQ: ONCS), a company developing intratumoral cancer immunotherapies, will present a trial-in-progress poster presentation from its global, multi-center, registration-directed...

ONCS : 1.40 (+0.72%)
OncoSec Provides Highlights from Research Reception at AACR Annual Meeting 2018

OncoSec Medical Incorporated (OncoSec) (NASDAQ: ONCS), a company developing intratumoral cancer immunotherapies, today provided highlights from its Research Reception held on Sunday, April 15, 2018, during...

ONCS : 1.40 (+0.72%)
OncoSec to Host Research Reception During the 2018 American Association of Cancer Research Annual Meeting

OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company developing intratumoral cancer immunotherapies, today announced it will host a Research Reception at the 2018 American Association of Cancer...

ONCS : 1.40 (+0.72%)
Biotech Market Poised to Reach 2015 Highs

FN Media Group Presents Microcapspeculators.com News Commentary

PPCHD : 1.2000 (+20.00%)
INNT : 6.94 (+1.61%)
PPCB : 0.0660 (+3.12%)
ONCS : 1.40 (+0.72%)
GERN : 5.46 (-0.73%)
LPTX : 6.59 (-4.08%)
What's Happening with These Biotech Stocks? -- OncoSec Medical, OvaScience, Pacific Biosciences of California, and Pieris Pharma

WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on ONCS, OVAS, PACB, and PIRS which can be accessed for free by signing up to www.wallstequities.com/registration....

PACB : 4.81 (-0.82%)
ONCS : 1.40 (+0.72%)
OVAS : 0.77 (+6.94%)
PIRS : 5.35 (+1.33%)
OncoSec Announces Strategic Relocation Of Office And Laboratories

OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company developing intratumoral cancer immunotherapies, today announced a strategic relocation of its office and lab in San Diego that is expected...

ONCS : 1.40 (+0.72%)
OncoSec To Present At The Oppenheimer's 28th Annual Healthcare Conference

OncoSec Medical Incorporated (OncoSec) (NASDAQ: ONCS), a company developing intratumoral cancer immunotherapies, today announced that Daniel J. O'Connor, Chief Executive Officer of OncoSec, will present...

ONCS : 1.40 (+0.72%)
OncoSec's Intratumoral IL-12 In Metastatic Triple Negative Breast Cancer (TNBC) Selected For Oral Poster Presentation At The American Association For Cancer Research (AACR) Annual Meeting 2018

OncoSec Medical Incorporated (OncoSec) (NASDAQ: ONCS), a company developing intratumoral cancer immunotherapies, today announced that clinical and immunological data from its OMS-I140 clinical trial of...

ONCS : 1.40 (+0.72%)

Van Meerten Stock Picks

Tesla According to Peter Lynch
Today's Barchart Chart of the Day will be the auto maker Tesla (TSLA).
TSLA +0.77
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.
Free Commodities Newsletter

Get prepared for your trading day with

Barchart's Commodity Futures Morning Update Email

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

cmdty Insider - Ag Market Commentary

Today's Commentary

Corn futures closed the Friday session with most contracts 4 to 5 cents in the green. Nearby Dec was up 1.56% over the course of the week. A private export sale this morning was shown for 121,700 MT of 18/19 corn to unknown by the USDA. Total corn ex...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar